M&A Deal Summary |
|
|---|---|
| Date | 2023-09-06 |
| Target | Atlantic Therapeutics |
| Sector | Medical Products |
| Buyer(s) | Caldera Medical |
| Sellers(s) |
Andera Partners
Atlantic Bridge EQT Life Sciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2002 |
| Sector | Medical Products |
Caldera Medical is a medical device company solely focused on women’s health. Caldera Medical develop, build and market best in class surgical products for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Caldera Medical was founded in 2002 and is based in Westlake Village, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Medical Products M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 2 of 3 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-01 |
NovaTract
New Haven, Connecticut, United States NovaTract is a developer of a specialized, next-generation surgical tool, based upon technology licensed from Yale University. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-10-08 |
Luminelle360
Raleigh, North Carolina, United States Luminelle360 offers visualization and a simplified workflow, empowering physicians to deliver superior care in both clinical and surgical settings, Luminelle360 is operated by UVision 360 which designs and develops innovative, minimally invasive hysteroscopy and cystoscopy systems that enhance precision and patient outcomes in gynecologic procedures. Luminelle360 is based in Raleigh, North Carolina. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 37 of 42 |
| Sector: Medical Products M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 12 of 15 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2023 M&A | 6 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-04-25 |
Scalian
Labege, France Scalian is an engineering consulting firm that provides industrial project management services for issues pertaining to supply chain (costs, quality, deadlines, performance), the architecture and development of embedded digital systems and information system applications, big data, and AI. It also addresses project optimization and organizational performance issues, as well as provides digital transformation support for industry and service sector leaders. Scalian was founded in 1989 and is based in Labege, France. |
Sell | €965M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-29 |
Meotec
Boulogne-Billancourt, France Meotec is a consulting firm specializing in project and purchasing management. More than 300 consultants support customers in five different skills: project management, procurement, economic performance, quality and processes, and interim management. Meotec was founded in 2005 and is based in Boulogne-Billancourt, France. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2006 |
| PE ASSETS | 1.0B EUR |
| Size | Middle-Market |
| Type | Sector Agnostic |
Atlantic Bridge is a growth capital firm focused on mid-market technology businesses across Europe, the US, Middle East, and China. Specific areas of interest include machine learning, robotics, computer visioning, cloud, IoT and big data. Atlantic Bridge generally prefers 'domain-specific companies' as well as businesses that can benefit from transatlantic opportunities. Atlantic Bridge was formed in 2006 and is based in Dublin.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 22 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 20 of 20 |
| Country: Ireland M&A | 5 of 5 |
| Year: 2023 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-12 |
Swrve
San Francisco, California, United States Swrve is the marketing and customer engagement platform that helps major brands confidently scale communications over millions of customers in real-time. Swrve’s Mobile Engagement Platform empowers digital marketers to create the ideal mobile customer experience. Swrve was founded in 2009 and is based in San Francisco, California. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 9 |
| Sector: Medical Products M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 2 of 7 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-09 |
Perfuze
Galway, Ireland Perfuze is a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke. Perfuze was founded in 2018 and is based in Galway, Ireland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-14 |
Amolyt Pharma
Ecully, France Amolyt Pharma is a clinical-stage biotechnology company, building therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma was founded in 2015 and is based in Ecully, France. |
Sell | $1.1B |